Dr. Sarah Sharman is a registered patent agent with in the Intellectual Property Practice of Smith, Gambrell, and Russell, LLP in the areas of chemistry, biotechnology and pharmaceuticals.
Dr. Sharman assists with drafting patent applications, prosecuting U.S. patent applications, and corresponding with foreign associates to guide the prosecution of foreign applications. She has experience in a diverse range of research disciplines including the areas of biochemistry, cancer biology, immunology, molecular biology, and biotechnology.
As a graduate student, Dr. Sharman’s research focused on the prevention and treatment of constipation and colorectal cancer by increasing cGMP signaling in the colon mucosa through the use of PDE-5 inhibitors and GC-C agonists. This research led to two first-authored, peer-reviewed manuscripts and numerous poster presentations at national meetings.
Dr. Sharman received her B.S. in Biology and Psychology from Birmingham Southern College. She earned her Ph.D. in Biochemistry and Cancer Biology from the Medical College of Georgia at Augusta University. Dr. Sharman is a registered patent agent admitted to practice before the United States Patent and Trademark Office